INTRODUCTION: Cell-adhesion molecules play important roles involving the malignant phenotypes of human cancer cells. However, detailed characteristics of aberrant expression status of cell-adhesion molecules in malignant mesothelioma (MM) cells and their possible biological roles for MM malignancy remain poorly understood. METHODS: DNA microarray analysis was employed to identify aberrantly expressing genes using 20 MM cell lines. Activated leukocyte cell-adhesion molecule (ALCAM) expression in MM cell lines was analyzed with quantitative reverse transcription-polymerase chain reaction and Western blot analyses in 47 primary MM specimens with immunohistochemistry. ALCAM knockdown in MM cell lines was performed with lentivirus-mediated short hairpin RNA (shRNA) transduction. Purified soluble ALCAM (sALCAM) protein was used for in vitro experiments, whereas MM cell lines infected with the sALCAM-expressing lentivirus were tested for tumorigenicity in vivo. RESULTS: ALCAM, a member of the immunoglobulin superfamily, was detected as one of the most highly upregulated genes among 103 cell-adhesion molecules with microarray analysis. Elevated expression levels of ALCAM messenger RNA and protein were detected in all 20 cell lines. Positive staining of ALCAM was detected in 26 of 47 MM specimens (55%) with immunohistochemistry. ALCAM knockdown with shRNA suppressed cell migration and invasion of MM cell lines. Purified sALCAM protein impaired the migration and invasion of MM cells in vitro, and the infection of sALCAM-expressing virus into MM cells significantly prolonged survival periods of MM-transplanted nude mice in vivo. CONCLUSION: Our study suggests that overexpression of ALCAM contributes to tumor progression in MM and that ALCAM might be a potential therapeutic target of MM.
INTRODUCTION: Cell-adhesion molecules play important roles involving the malignant phenotypes of humancancer cells. However, detailed characteristics of aberrant expression status of cell-adhesion molecules in malignant mesothelioma (MM) cells and their possible biological roles for MM malignancy remain poorly understood. METHODS: DNA microarray analysis was employed to identify aberrantly expressing genes using 20 MM cell lines. Activated leukocyte cell-adhesion molecule (ALCAM) expression in MM cell lines was analyzed with quantitative reverse transcription-polymerase chain reaction and Western blot analyses in 47 primary MM specimens with immunohistochemistry. ALCAM knockdown in MM cell lines was performed with lentivirus-mediated short hairpin RNA (shRNA) transduction. Purified soluble ALCAM (sALCAM) protein was used for in vitro experiments, whereas MM cell lines infected with the sALCAM-expressing lentivirus were tested for tumorigenicity in vivo. RESULTS:ALCAM, a member of the immunoglobulin superfamily, was detected as one of the most highly upregulated genes among 103 cell-adhesion molecules with microarray analysis. Elevated expression levels of ALCAM messenger RNA and protein were detected in all 20 cell lines. Positive staining of ALCAM was detected in 26 of 47 MM specimens (55%) with immunohistochemistry. ALCAM knockdown with shRNA suppressed cell migration and invasion of MM cell lines. Purified sALCAM protein impaired the migration and invasion of MM cells in vitro, and the infection of sALCAM-expressing virus into MM cells significantly prolonged survival periods of MM-transplanted nude mice in vivo. CONCLUSION: Our study suggests that overexpression of ALCAM contributes to tumor progression in MM and that ALCAM might be a potential therapeutic target of MM.
Authors: Shingo Inaguma; Jerzy Lasota; Zengfeng Wang; Piotr Czapiewski; Renata Langfort; Janusz Rys; Joanna Szpor; Piotr Waloszczyk; Krzysztof Okoń; Wojciech Biernat; Hiroshi Ikeda; David S Schrump; Raffit Hassan; Markku Miettinen Journal: Hum Pathol Date: 2017-08-12 Impact factor: 3.466
Authors: Yuen Yee Cheng; Casey M Wright; Michaela B Kirschner; Marissa Williams; Kadir H Sarun; Vladimir Sytnyk; Iryna Leshchynska; J James Edelman; Michael P Vallely; Brian C McCaughan; Sonja Klebe; Nico van Zandwijk; Ruby C Y Lin; Glen Reid Journal: Mol Cancer Date: 2016-06-01 Impact factor: 27.401
Authors: Andrew J Sanders; Sioned Owen; Liam D Morgan; Fiona Ruge; Ross J Collins; Lin Ye; Malcolm D Mason; Wen G Jiang Journal: Oncotarget Date: 2019-10-29
Authors: Justine Münsterberg; Desirée Loreth; Laura Brylka; Stefan Werner; Jana Karbanova; Monja Gandrass; Svenja Schneegans; Katharina Besler; Fabienne Hamester; José Ramon Robador; Alexander Thomas Bauer; Stefan Werner Schneider; Michaela Wrage; Katrin Lamszus; Jakob Matschke; Yogesh Vashist; Güntac Uzunoglu; Stefan Steurer; Andrea Kristina Horst; Leticia Oliveira-Ferrer; Markus Glatzel; Thorsten Schinke; Denis Corbeil; Klaus Pantel; Cecile Maire; Harriet Wikman Journal: Neuro Oncol Date: 2020-07-07 Impact factor: 12.300